Industrial Microbiology Testing Services Market Analysis

  • Report ID: 5340
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Industrial Microbiology Testing Services Market Analysis

Test Type (Sterility Testing, Microbial Limits Testing, Bio-burden Testing, Water Testing, Air Monitoring Tests)

The sterility testing segment in the industrial microbiology testing services market is estimated to gain a robust revenue share of 32% in the coming years owing to the increasing launch of drugs. Successful drug launches have traditionally been a growth driver for pharmaceutical businesses as drug development is being automated using AI and creating opportunities for quicker, less expensive medications. 

Sterility testing is a GMP microbiology requirement of pharmaceutical items to guarantee that there are no detectable viable contaminating microorganisms in a product, and verifies that the supplied product is suitably sterile It is necessary for both ordinary release testing and the sterilization validation process so that it can be transmitted for additional use. These tests are essential for maintaining product sterility and ensuring quality control which entails putting a certain amount of a therapeutic product through two filters that are intended to hold microorganisms after that, the filter is rinsed to make sure no medicinal product is left on it as that could stop the growth of microorganisms. 

Furthermore, the rules for sterility tests for biological products are being changed by the Food and Drug Administration (FDA) to encourage the use of the most suitable and advanced test procedures for biological product safety assurance. For instance, in 2021, the FDA continued a decade-long trend of increasing medicine approvals by approving more than 45 new medications, and over 53 were authorized by the European Medicines Agency.

Additionally, the microbial limits testing segment is poised to gain a notable share during the forecast timeframe. The microbial limit test (MLT) is used to determine the quantity and type of specific live microorganisms present in non-sterile industrial samples from pharmaceutical goods to evaluate whether or not a product contains particular undesirable organisms and to determine whether a pharmaceutical product conforms with a set standard for microbiological quality.

End-User (Food & Beverages, Pharmaceutical & Biotechnology, Agricultural, Environmental, Cosmetic and Personal Care)

The pharmaceutical & biotechnology segment is expected to account for 30% share of the global industrial microbiology testing services market by 2037. The second most popular test used by industrial microbiology to assess raw materials is microbial testing which is increasingly used by the pharmaceutical and biotechnology industries as they have specific needs, which are addressed by microbial solutions.

Besides this, the food & beverages segment is anticipated to gain significant share by the year 2037. The food sample's food additives, pollutants, and toxins are examples of food safety parameters to assure food quality and safety which are tested by microbial solutions.

Our in-depth analysis of the global industrial microbiology testing services market includes the following segments:

          Test Type

  • Sterility Testing
  • Microbial Limits Testing
  •  Bio-burden Testing
  • Water Testing
  • Air Monitoring Tests

          End-User

  • Food & Beverages
  •  Pharmaceutical & Biotechnology
  • Agricultural
  •  Environmental
  • Cosmetic and Personal Care

          Product Type

  • Reaction Consumables
  •  Equipment and Systems
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5340
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of non-invasive respiratory monitoring is assessed at USD 3.82 billion.

The industrial microbiology testing services market size was over USD 3.56 billion in 2024 and is projected to reach USD 11.18 billion by 2037, witnessing around 9.2% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of infectious diseases and the growing government initiatives to maintain products quality in pharmaceutical and food industry will boost the market growth.

North America industry is estimated to dominate majority revenue share of 45% by 2037, impelled by rising investment in the development of vaccines in the region.

The major players in the market are Charles River Laboratories, Spectro Analytical Labs Pvt. Ltd., Pace® Analytical Services, Biotech Testing Services, Merck KGaA, TÜV SÜD, Precise Analytics Lab, Eurofins Scientific, Biocare Research (India) Pvt. Ltd., STERIS, Intertek Group Plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample